EDGAR·FLOW

Karyopharm Therapeutics Inc. — Form 8-K

Filed November 5, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 92/100
What the filing says
Karyopharm Therapeutics Inc. filed an 8-K on November 5, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing indicates the company has received notification regarding failure to meet continued listing standards, though specific details of which listing rule was breached, cure periods, or remediation steps are not provided in the document header or summary. This represents a critical threat to the company's public market status.
Why this rating

Delisting notice is existential for a $37M market-cap company. Loss of public listing removes liquidity, access to capital, and institutional investor eligibility—potentially fatal.

Extracted items
Tradability signal
NO TRADE

No trade: price $0.06 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
before filing · preread
$0.07 ▲ 28.91%
at our read · unknown
$0.05
+10 min · unknown
$0.06 ▲ 3.68%
+30 min · unknown
$0.06 ▲ 4.05%
+1 hr · unknown
$0.05 ▼ 0.55%
+4 hrs · unknown
$0.06 ▲ 13.26%

The stock had already moved -22.43% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ KPTI · stock on Yahoo Finance ↗

See more from November 5, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.